MedPath

Comparison of Three Pre-oxygenation Strategies

Not Applicable
Recruiting
Conditions
Emergencies
Anesthesia
Interventions
Other: Preoxygenation
Registration Number
NCT06370689
Lead Sponsor
Institute of Mountain Emergency Medicine
Brief Summary

Study objective: Comparing the efficacy of three different preoxygenation strategies, i.e. non-rebreather face mask (NRM), bag-valve-mask (BVM) with and BVM without additional positive end-expiratory pressure (PEEP) in three subgroups of spontaneously breathing volunteers.

Study endpoints

Primary Endpoint:

Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions.

Secondary endpoints:

* Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions.

* Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)

* Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5

* Time to reaching an Oxygen Reserve Index (ORi) =1

* Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.

Number of participants 15 participants per subgroup, i.e. 45 participants in total.

Inclusion criteria

* Normal-weight adults (body mass index, BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II

* Adults with a BMI 25-39.9 kg/m2 with and ASA score \<3

* Healthy (ASA I) children aged 6-12 years Exclusion criteria ASA 3, Age \< 6 and age 12-18, pregnant women, missing informed consent, signs and symptoms of an acute respiratory illness on the study day.

After informed consent and a medical check-up, baseline measurements will be done for 10 minutes (peripheral oxygen saturation SpO2, ORI, regional ventilation). Then the participants will undergo 3 different preoxygenation sessions with the 3 interfaces (i.e. non-rebreather facemask with reservoir and a bag-valve-mask with and without PEEP) in a randomized order and a 20 min washout between the sessions. Each preoxygenation session is conducted in a supine position and will be proceeded until the measured FeO2 (end expiratory O2 fraction) reaches 90% or up to a maximum time of 3 min. Afterwards 10 min of SpO2, ORI and regional ventilation measurements will follow.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Normal-weight adults (BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II
  • Adults with a BMI 25-39.9 kg/m2 with and ASA score <3
  • Healthy (ASA I) children aged 6-12 years
Exclusion Criteria
  • ASA 3
  • Age < 6 and age 12-18
  • pregnant women
  • missing informed consent
  • signs and symptoms of an acute respiratory illness on the study day

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
BVM with PEEP in children 6-12 yrsPreoxygenationBag valve mask with positive end-expiratory pressure (PEEP) in children 6-12 yrs
BVM without PEEP in overweight/obese adultsPreoxygenationBag valve mask without positive end-expiratory pressure (PEEP) in overweight/obese adults
BVM without PEEP in normal weight adultsPreoxygenationBag valve mask without positive end-expiratory pressure (PEEP) in normal weight adults
BVM with PEEP in overweight/obese adultsPreoxygenationBag valve mask with positive end-expiratory pressure (PEEP) in overweight/obese adults
BVM with PEEP in normal weight adultsPreoxygenationBag valve mask with positive end-expiratory pressure (PEEP) in normal weight adults
BVM without PEEP in children 6-12 yrsPreoxygenationBag valve mask without positive end-expiratory pressure (PEEP) in children 6-12 yrs
NRM - Non-rebreather mask in normal weight adultsPreoxygenationNon-rebreather mask in normal weight adults
NRM - Non-rebreather mask in children 6-12 yrsPreoxygenationNon-rebreather mask in children 6-12 yrs
NRM - Non-rebreather mask in overweight/obese adultsPreoxygenationNon-rebreather mask in overweight/obese adults
Primary Outcome Measures
NameTimeMethod
Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions.After 3 minutes of preoxygenation

Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions between the three arms.

Secondary Outcome Measures
NameTimeMethod
Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.Washout phase after the 3 min preoxygenation sessions.

Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.

Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)After 1.5 and 3 minutes of preoxygenation

Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)

Time to reaching an Oxygen Reserve Index (ORi) =1Variable, timepoint during the 3 min preoxygenation session

Time to reaching an Oxygen Reserve Index (ORi) =1

Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions.After 3 minutes of preoxygenation

Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions. ORi ranges from 0.0 to 1.0 and reflects the partial pressure of oxygen in arterial blood (PaO2 80-200).

Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5Variable, timepoint during the 3 min preoxygenation session

Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5

Trial Locations

Locations (1)

TerraXCube

🇮🇹

Bolzano, Italy

© Copyright 2025. All Rights Reserved by MedPath